Leslie Holsinger

Leslie Holsinger

Company: Cortexyme

Job title: Executive Vice President of Research & Development

Seminars:

Live Q&A With Your Expert Speakers 3:30 pm

Read more

day: Day One

Use of Novel Biomarkers of P. Gingivalis Infection & Neuroinflammation in the GAIN Trial; An Ongoing Phase 2/3 Clinical Trial Assessing the Activity of Atuzaginstat in Patients with Mild to Moderate Alzheimer’s Disease 2:10 pm

Application of mechanism-specific biomarkers in a trial targeting an infectious pathogen found in the brain of Alzheimer’s patients and tied to neurodegeneration and neuroinflammation Development of novel biomarkers that assess baseline subject characteristics which may be predictive of response Clinical update on baseline biomarker analysis and subject characterization in the GAIN trial with CSF and…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.